Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.090
-0.050 (-4.39%)
At close: Apr 25, 2025, 4:00 PM
1.100
+0.010 (0.92%)
After-hours: Apr 25, 2025, 5:03 PM EDT
PACB Analyst Ratings
Total Analysts
11
Consensus Rating
Buy
Price Target
$2.45
Upside
+124.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +175.23% | Apr 10, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $6 → $2 | Buy | Maintains | $6 → $2 | +83.49% | Mar 25, 2025 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2.5 → $2 | Hold | Reiterates | $2.5 → $2 | +83.49% | Feb 20, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $1.75 → $1.5 | Hold | Maintains | $1.75 → $1.5 | +37.61% | Feb 18, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +129.36% | Feb 18, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +129.36% | Feb 14, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $2.25 → $1.75 | Hold | Maintains | $2.25 → $1.75 | +60.55% | Jan 23, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +83.49% | Nov 11, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +450.46% | Nov 11, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $2 → $2.5 | Hold | Maintains | $2 → $2.5 | +129.36% | Nov 11, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +542.20% | Aug 28, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $3.5 → $2.5 | Buy | Maintains | $3.5 → $2.5 | +129.36% | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +83.49% | Aug 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3.5 | Buy | Reiterates | $3.5 | +221.10% | Aug 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3.5 → $3 | Strong Buy | Maintains | $3.5 → $3 | +175.23% | Aug 8, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +266.97% | Jun 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.